ALDMS Fundamental Analysis - DIAGNOSTIC MEDICAL SYSTEMS

Fundamental Rating

Overall ALDMS gets a fundamental rating of 3 out of 10. We evaluated ALDMS against 59 industry peers in the Health Care Equipment & Supplies industry. ALDMS has a bad profitability rating. Also its financial health evaluation is rather negative. ALDMS has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALDMS had negative earnings in the past year.

ALDMS had a positive operating cash flow in the past year.

In the past 5 years ALDMS always reported negative net income.

In multiple years ALDMS reported negative operating cash flow during the last 5 years.

1.2 Ratios

ALDMS has a Return On Assets of -5.34%. This is in the lower half of the industry: ALDMS underperforms 62.71% of its industry peers.

ALDMS's Return On Equity of -22.44% is on the low side compared to the rest of the industry. ALDMS is outperformed by 66.10% of its industry peers.

		Industry Rank	Sector Rank
ROA	-5.34%
ROE	-22.44%
ROIC	N/A

ROA(3y)-9.22%

ROA(5y)-9.28%

ROE(3y)-35.31%

ROE(5y)-31.48%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALDMS (39.92%) is worse than 74.58% of its industry peers.

In the last couple of years the Gross Margin of ALDMS has grown nicely.

The Profit Margin and Operating Margin are not available for ALDMS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	39.92%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.05%

GM growth 5Y2.79%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALDMS does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALDMS has more shares outstanding than it did 1 year ago.

The number of shares outstanding for ALDMS has been increased compared to 5 years ago.

The debt/assets ratio for ALDMS has been reduced compared to a year ago.

2.2 Solvency

ALDMS has an Altman-Z score of 0.87. This is a bad value and indicates that ALDMS is not financially healthy and even has some risk of bankruptcy.

ALDMS has a worse Altman-Z score (0.87) than 66.10% of its industry peers.

ALDMS has a debt to FCF ratio of 5.57. This is a neutral value as ALDMS would need 5.57 years to pay back of all of its debts.

ALDMS has a Debt to FCF ratio (5.57) which is in line with its industry peers.

ALDMS has a Debt/Equity ratio of 0.90. This is a neutral value indicating ALDMS is somewhat dependend on debt financing.

With a Debt to Equity ratio value of 0.90, ALDMS is not doing good in the industry: 77.97% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	0.9
Debt/FCF	5.57
Altman-Z	0.87

ROIC/WACCN/A

WACC6.72%

2.3 Liquidity

A Current Ratio of 1.29 indicates that ALDMS should not have too much problems paying its short term obligations.

ALDMS has a Current ratio of 1.29. This is in the lower half of the industry: ALDMS underperforms 61.02% of its industry peers.

ALDMS has a Quick Ratio of 1.29. This is a bad value and indicates that ALDMS is not financially healthy enough and could expect problems in meeting its short term obligations.

ALDMS has a Quick ratio of 0.67. This is in the lower half of the industry: ALDMS underperforms 72.88% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.29
Quick Ratio	0.67

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.00% over the past year.

ALDMS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.29%.

The Revenue has been growing by 8.24% on average over the past years. This is quite good.

EPS 1Y (TTM)40%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%87%

Revenue 1Y (TTM)9.29%

Revenue growth 3Y7.62%

Revenue growth 5Y8.24%

Sales Q2Q%8.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

Based on estimates for the next years, ALDMS will show a quite strong growth in Revenue. The Revenue will grow by 11.55% on average per year.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year19.4%

Revenue Next 2Y13.86%

Revenue Next 3Y11.55%

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALDMS. In the last year negative earnings were reported.

The Price/Forward Earnings ratio is 11.80, which indicates a very decent valuation of ALDMS.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ALDMS indicates a rather cheap valuation: ALDMS is cheaper than 81.36% of the companies listed in the same industry.

ALDMS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	11.8

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALDMS indicates a rather cheap valuation: ALDMS is cheaper than 100.00% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	6.11
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALDMS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIAGNOSTIC MEDICAL SYSTEMS

EPA:ALDMS (6/17/2025, 7:00:00 PM)

1.215

-0.03 (-2.8%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners6.23%

Ins Owner ChangeN/A

Market Cap21.99M

Analysts86.67

Price Target1.84 (51.44%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)4.28%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	11.8
P/S	0.48
P/FCF	6.11
P/OCF	6.11
P/B	1.71
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.15

EYN/A

EPS(NY)0.1

Fwd EY8.48%

FCF(TTM)0.2

FCFY16.37%

OCF(TTM)0.2

OCFY16.37%

SpS2.55

BVpS0.71

TBVpS-0.33

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-5.34%
ROE	-22.44%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	39.92%
FCFM	7.82%

ROA(3y)-9.22%

ROA(5y)-9.28%

ROE(3y)-35.31%

ROE(5y)-31.48%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.05%

GM growth 5Y2.79%

F-Score6

Asset Turnover0.85

Health

		Industry Rank	Sector Rank
Debt/Equity	0.9
Debt/FCF	5.57
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.29
Quick Ratio	0.67
Altman-Z	0.87

F-Score6

WACC6.72%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)40%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%87%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)9.29%

Revenue growth 3Y7.62%

Revenue growth 5Y8.24%

Sales Q2Q%8.7%

Revenue Next Year19.4%

Revenue Next 2Y13.86%

Revenue Next 3Y11.55%

Revenue Next 5YN/A

EBIT growth 1Y35.01%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year1225%

EBIT Next 3Y158.38%

EBIT Next 5YN/A

FCF growth 1Y318.91%

FCF growth 3YN/A

FCF growth 5Y58.15%

OCF growth 1Y318.91%

OCF growth 3YN/A

OCF growth 5Y58.15%

DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens